AIMCA
MRTX

Alberta Investment Management Corp (AIMCo)’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-44,300
Closed -$2.6M – 1085
2023
Q4 		$2.6M Buy
+44,300
New +$2.49M 0.02% 357

Other funds holding MRTX

S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s MRTX Position: Q1 2024 in Review

Alberta Investment Management Corp (AIMCo) sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 44,300 shares — an estimated $2.6M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in MRTX in Q4 2023 and held it in 1 quarter. The position peaked at $2.6M in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 44,300 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $2.6M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Alberta Investment Management Corp (AIMCo)'s Mirati Therapeutics, Inc. Common Stock position peaked at $2.6M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2024, filed 15 May 2024.